1 pending office actions • 0 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Zyno Medical LLC is managing 1 pending office action within its patent portfolio. The prosecution involves 1 distinct examiner, which indicates that all current pending matters are being reviewed by a single individual. GRASMEDER, SARAH DYMPNA is the busiest examiner for the company, with the pending office action. This examiner accounts for the entirety of the portfolio's current pending workload, streamlining the communication process for these specific patent filings into a single channel of review at the patent office.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GRASMEDER, SARAH DYMPNA | 1 | 72.2% | +32.1% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18443649 | Transcutaneous Drug Delivery System with Pump Backpack | GRASMEDER, SARAH DYMPNA | — |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18443649 | Transcutaneous Drug Delivery System with Pump Backpack | GRASMEDER, SARAH DYMPNA | — | §103 | Non-Final OA | — | Pending | Feb 16, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial